Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Toshihiko Satoh is active.

Publication


Featured researches published by Toshihiko Satoh.


Biochemical Pharmacology | 1993

Effects of NB-598, a potent squalene epoxidase inhibitor, on the apical membrane uptake of cholesterol and basolateral membrane secretion of lipids in Caco-2 cells

Masahiro Horie; Yoshikazu Iwasawa; Toshihiko Satoh; Akiko Shimizu; Yasufumi Nagata; Toshio Kamei

Caco-2 cells grown on membrane filters were used as a model to study the effects of NB-598, an inhibitor of squalene epoxidase, on cholesterol absorption from the intestinal epithelia. NB-598 (10 microM) inhibited the synthesis of sterol and sterol ester from [14C]acetate without affecting the synthesis of other lipids such as phospholipids (PL), free fatty acids (FFA) and triacylglycerol (TG). When labeled lipid was apically loaded as a micellar lipid solution into Caco-2 cell cultures, NB-598 reduced basolaterally secreted radioactivity in cholesterol, cholesterol ester, PL and TG. Furthermore, NB-598 suppressed the basolateral secretion of apolipoprotein (apo) B. When microsomes prepared from control Caco-2 cells were incubated with 10 microM NB-598, acyl CoA:cholesterol acyltransferase (ACAT) activity was inhibited slightly. After incubating Caco-2 cells with 10 microM NB-598, a slight reduction in cellular ACAT activity was also observed. These results suggest that suppression of the secretion of particles containing apo B and reduction of cellular ACAT activity in the intestinal epithelia are part of the mechanism of the cholesterol-lowering effect of NB-598.


Journal of Lipid Research | 1990

Regulation of squalene epoxidase in HepG2 cells.

Yusuke Hidaka; Toshihiko Satoh; Toshio Kamei


Archive | 1997

N,N-disubstituted amic acid derivatives

Yoshikazu Iwasawa; Tetsuya Aoyama; Kumiko Kawakami; Sachie Arai; Toshihiko Satoh; Yoshiaki Monden


Journal of Lipid Research | 1990

Regulation of squalene epoxidase activity in rat liver.

Toshihiko Satoh; Yusuke Hidaka; Toshio Kamei


Molecular Pharmacology | 1998

J-104,871, a novel farnesyltransferase inhibitor, blocks Ras farnesylation in vivo in a farnesyl pyrophosphate-competitive manner.

Mari Yonemoto; Toshihiko Satoh; Hiroharu Arakawa; Ikuko Suzuki-Takahashi; Yoshiaki Monden; Tsutomu Kodera; Kenji Tanaka; Tetsuya Aoyama; Yoshikazu Iwasawa; Toshio Kamei; Susumu Nishimura; Koji Tomimoto


Biological & Pharmaceutical Bulletin | 1993

Enzymatic Properties of Squalene Epoxidase from Saccharomyces cerevisiae

Toshihiko Satoh; Masahiro Horie; Hisako Watanabe; Yoshimi Tsuchiya; Toshio Kamei


Journal of Medicinal Chemistry | 1998

A new class of highly potent farnesyl diphosphate-competitive inhibitors of farnesyltransferase.

Tetsuya Aoyama; Toshihiko Satoh; Mari Yonemoto; Jun Shibata; Katsumasa Nonoshita; Sachie Arai; Kumiko Kawakami; Yoshikazu Iwasawa; Hideki Sano; Kenji Tanaka; Yoshiaki Monden; Tsutomu Kodera; Hiroharu Arakawa; Ikuko Suzuki-Takahashi; Toshio Kamei; Koji Tomimoto


Archive | 1991

Substituted amine derivatives having anti-hyperlipemia activity

Yoshimi Tsuchiya; Takashi Nomoto; Masahiro Hayashi; Yoshikazu Iwasawa; Hitoshi Masaki; Mitsuru Ohkubo; Yumiko Sakuma; Yasufumi Nagata; Toshihiko Satoh; Toshio Kamei


Archive | 1997

Cyclic amic acid derivatives

Yoshikazu Iwasawa; Tetsuya Aoyama; Kumiko Kawakami; Sachie Arai; Toshihiko Satoh; Yoshiaki Monden


Archive | 1993

Substituted heterocyclic derivative having squalene epoxidase inhibition action and its use

Yoshimi Tsuchiya; Takashi Nomoto; Morihiro Mitsuya; Katsumasa Nonoshita; Masahiro Hayashi; Toshihiko Satoh; Yoshio Sawasaki; Toshio Kamei

Collaboration


Dive into the Toshihiko Satoh's collaboration.

Researchain Logo
Decentralizing Knowledge